Production (Stage)
CareRx Corporation
CRRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.25% | -1.65% | -2.63% | -4.44% | -1.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.25% | -1.65% | -2.63% | -4.44% | -1.52% |
| Cost of Revenue | -6.58% | -3.67% | -2.81% | -6.89% | -3.52% |
| Gross Profit | -5.44% | 3.49% | -2.19% | 1.91% | 3.63% |
| SG&A Expenses | -6.84% | 10.84% | -4.25% | 1.24% | 0.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.65% | 0.20% | -3.20% | -4.73% | -2.53% |
| Operating Income | 10.32% | -88.45% | 22.62% | 12.50% | 70.65% |
| Income Before Tax | 141.25% | 44.47% | 75.37% | 36.62% | 75.86% |
| Income Tax Expenses | -- | 118.00% | -- | -- | -- |
| Earnings from Continuing Operations | 141.25% | 41.03% | 75.37% | -171.98% | 75.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 141.25% | 41.03% | 75.37% | -171.98% | 75.86% |
| EBIT | 10.32% | -88.45% | 22.62% | 12.50% | 70.65% |
| EBITDA | -14.98% | -63.63% | 29.35% | -18.94% | 15.72% |
| EPS Basic | 139.06% | 43.32% | 76.34% | -169.14% | 77.70% |
| Normalized Basic EPS | 325.00% | -45.26% | 126.09% | 67.46% | 83.22% |
| EPS Diluted | 132.43% | 43.32% | 76.34% | -175.34% | 74.22% |
| Normalized Diluted EPS | 316.67% | -45.26% | 126.09% | 64.35% | 83.22% |
| Average Basic Shares Outstanding | 4.79% | 3.89% | 4.08% | 4.28% | 8.19% |
| Average Diluted Shares Outstanding | 8.89% | 3.89% | 4.08% | -4.81% | 8.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |